Rabenosyn-5 (541-552)

Rabenosyn-5 (541-552) is a synthetic peptide fragment corresponding to amino acids 541 through 552 of the Rabenosyn-5 protein, a key effector involved in early endosomal trafficking and membrane dynamics. As a functionally significant segment derived from the C-terminal region, this peptide is valued for its role in elucidating protein-protein interactions and regulatory mechanisms within the endocytic pathway. Researchers utilize this fragment to dissect the molecular determinants underlying endosomal sorting and vesicular transport, making it a pivotal tool for studies focused on intracellular trafficking, membrane tethering, and the orchestration of Rab GTPase-mediated processes.

Protein Interaction Mapping: In the context of protein interaction studies, the Rabenosyn-5 (541-552) peptide serves as a valuable probe to identify and characterize binding partners that associate with the C-terminal domain of Rabenosyn-5. By employing this defined sequence in pull-down assays, surface plasmon resonance, or co-immunoprecipitation experiments, investigators can delineate the specific motifs and residues responsible for mediating interactions with Rab5, EEA1, or other components of the endosomal machinery. This targeted approach enables a more granular understanding of the molecular architecture and signaling networks governing endosomal function.

Peptide Competition Assays: The peptide is frequently employed in competitive binding assays to disrupt or modulate endogenous protein-protein interactions involving Rabenosyn-5. By introducing the synthetic fragment into cell-free systems or cultured cells, researchers can assess the specificity and affinity of binding events, thereby validating the physiological relevance of candidate interactors. Such applications are instrumental in dissecting the dynamic regulation of endosomal sorting complexes and in mapping the critical determinants of cargo recognition and membrane association.

Structural and Biophysical Analysis: As a well-defined peptide sequence, Rabenosyn-5 (541-552) provides a tractable model for structural biology studies, including NMR spectroscopy and X-ray crystallography. Its use facilitates the elucidation of secondary structure elements, conformational preferences, and interaction surfaces pertinent to the C-terminal region of the full-length protein. Insights gained from these analyses inform not only the intrinsic folding properties of the peptide but also its role in mediating larger macromolecular assemblies within the endocytic pathway.

Antibody Generation and Epitope Mapping: The defined sequence of Rabenosyn-5 (541-552) is suitable for use as an immunogen in the production of polyclonal or monoclonal antibodies targeting the C-terminal domain of Rabenosyn-5. These antibodies are subsequently applied in immunodetection, localization, and quantification studies, enabling researchers to monitor the expression, distribution, and post-translational modifications of the native protein in various cellular contexts. Additionally, the peptide facilitates precise epitope mapping efforts, supporting the development of highly specific immunoreagents for advanced cell biology investigations.

Functional Modulation Studies: In experimental systems, the peptide fragment can be leveraged to modulate endosomal trafficking processes by acting as a dominant-negative inhibitor or functional mimic. Introduction of Rabenosyn-5 (541-552) into live-cell assays or reconstituted vesicle systems allows researchers to probe the consequences of altered protein-protein interactions on endosome morphology, cargo sorting, and membrane fusion events. These functional studies contribute to a deeper mechanistic understanding of endocytic regulation and the broader landscape of membrane trafficking in eukaryotic cells.

1. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

2. cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging

3. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

4. High fat diet and GLP-1 drugs induce pancreatic injury in mice

5. Emu oil in combination with other active ingredients for treating skin imperfections